Device Trial Radar · NCT02357381
eNeura SpringTMS Post-Market Observational US Study of Migraine
Last checked: Nov 20, 2026Latest source record: Jun 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
263
Actual
Start
Dec 1, 2014
Primary completion
Jul 1, 2016
Study completion Jul 1, 2016
Sponsor
- Lead sponsor
- eNeura, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 6, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center, prospective, non-randomized, single arm, open label, post-market, observational study to evaluate the use of the eneura, springtms system in reduction of migraine headache symptoms.
Conditions
- Headache
Interventions
eNeura SpringTMSDevice
Single pulse magnetic stimulation for prevention and/or treatment of migraine headache with or without aura.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Headache DaysTime frame: 3 months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Phoenix, Arizona
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.